Medicare Enrolled

Dr. Mark Weinstein, M.D.

Dermatology · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7950 FLOYD CURL DRIVE, San Antonio, TX 78229
2106143575
In practice since 2006 (19 years)
NPI: 1447369095 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weinstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weinstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Weinstein

Dr. Mark Weinstein is a dermatology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Weinstein performed 12,795 Medicare services across 3,807 unique beneficiaries.

Between the years covered by Open Payments, Dr. Weinstein received a total of $15,817 from 44 pharmaceutical and/or device companies across 900 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Weinstein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 5% volume in TX $15,817 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,795
Medicare services
Top 5% in TX for dermatology
3,807
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~673 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 5,497 $5 $10
Photodynamic therapy gel for precancerous skin 2,600 $1 $2
Office visit, established patient (20-29 min) 2,357 $61 $135
Destruction of precancerous skin growth, 1 1,648 $44 $125
Skin biopsy, tangential 174 $71 $155
New patient office or other outpatient visit, 15-29 minutes 146 $44 $135
Destruction of precancer skin growth, 15 or more growths 117 $123 $235
Simple or single drainage of skin abscess 63 $87 $180
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm 33 $129 $275
Destruction of skin growths (warts/lesions), 1-14 30 $65 $148
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 25 $127 $265
Biopsy of related skin growth, each additional growth 21 $39 $100
Injection into skin growth, more than 7 growths 20 $50 $115
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm 19 $87 $220
Injection into skin growth, 1-7 growths 18 $33 $95
Shaving of skin growth of body, arms, or legs, 0.5 cm or less 14 $59 $170
Application of light with debridement to destroy precancer skin growth 13 $202 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,817
Total received (2018-2024)
Avg $2,260/year across 7 years
Top 16% in TX for dermatology
44
Companies
900
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,817 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,480
2023
$3,009
2022
$2,470
2021
$1,830
2020
$1,435
2019
$1,983
2018
$1,611

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,976
AbbVie Inc.
$1,328
ABBVIE INC.
$1,256
Lilly USA, LLC
$1,091
Regeneron Healthcare Solutions, Inc.
$972
E.R. Squibb & Sons, L.L.C.
$904
Amgen Inc.
$834
GENZYME CORPORATION
$823
Ortho Dermatologics, a division of Bausch Health US, LLC
$772
UCB, Inc.
$650
AbbVie, Inc.
$638
PFIZER INC.
$625
Galderma Laboratories, L.P.
$537
LEO Pharma Inc.
$412
Sun Pharmaceutical Industries Inc.
$346
Novartis Pharmaceuticals Corporation
$321
Genentech USA, Inc.
$272
Dermavant Sciences, Inc.
$240
SUN PHARMACEUTICAL INDUSTRIES INC.
$224
Celgene Corporation
$220
Boehringer Ingelheim Pharmaceuticals, Inc.
$190
Mayne Pharma Inc.
$176
Sebela Pharmaceuticals Inc.
$156
Biofrontera Inc.
$146
Incyte Corporation
$132
Arcutis Biotherapeutics, Inc.
$80
Mylan Pharmaceuticals Inc.
$55
MAYNE PHARMA INC.
$50
Promius Pharma LLC
$50
Aclaris Therapeutics, Inc.
$46
Janssen Scientific Affairs, LLC
$41
Mission Pharmacal Company
$34
MAYNE PHARMA COMMERCIAL LLC
$28
Pierre Fabre Pharmaceuticals, Inc.
$27
GlaxoSmithKline, LLC.
$26
VYNE Pharmaceuticals Inc.
$25
Glenmark Therapeutics Inc.
$18
Organogenesis Inc.
$17
Mylan Institutional Inc.
$15
NOBELPHARMA AMERICA, LLC
$14
Almirall LLC
$13
EPI Health, LLC
$13
DERMIRA, INC.
$12
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 28.8% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ANGLED BLADE PLATES · Absorica LD · Actemra · Ameluz · Avar · BRYHALI · Bensal HP · Bimzelx · CIBINQO · COSENTYX · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · HUMIRA · HYFTOR · Hulio · Humira · ILUMYA · Ilumya · JUBLIA · LIBTAYO · Mupirocin Cream · NAFTIN · NUCALA · ONEXTON · OPZELURA · ORACEA · Odomzo · Olux · Otezla · PICATO · PRAMOSONE · PuraPly AM · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · Rituxan · SILIQ · SIVEXTRO · SKYRIZI · SOLODYN · SOOLANTRA · SORILUX · SPEVIGO · Sernivo Spray · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRIANEX 0.05% · Tremfya · VTAMA · Winlevi · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $124 per 100 Medicare services performed
Looking for a dermatology specialist in San Antonio?
Compare dermatologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
109
Per 100K population
5.4
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Weinstein is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), with low-engagement industry engagement in the top 16% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Weinstein experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Weinstein performed 5,497 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weinstein receive payments from pharmaceutical companies?
Yes. Dr. Weinstein received a total of $15,817 from 44 companies across 900 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weinstein's costs compare to other dermatologists in San Antonio?
Dr. Weinstein's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weinstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →